Abstract
Objective
To enhance the differentiation of mesenchymal stem cells (MSCs) and their epigenetic status by modification using hypomethylating agents (HMAs) and histone deacetylase inhibitors (HDACs).
Results
Treatment with 5-azacytidine or 5-azacytidine plus trichostatin A (TSA) increased expression of Runx-2, BDNF and Sox-9 compared with the control or TSA groups. Maximal increases of 4.1-, 4.5-, and 8.3-fold in Runx-2, BDNF, and Sox-9 transcript levels, respectively, were observed in the 5-azacytidine plus TSA group. Similar to the expression pattern of key regulatory molecules, differentiation to each lineage was also enhanced considerably in the 5-azacytidine or in the 5-azacytidine plus TSA groups. Quantitative analyses at the protein level showed 8.9-, 26.8-, 27.9-, and 28.5-fold upregulation of osterix, MAP-2, nestin, and type II collagen), respectively.
Conclusion
HMAs and HDACs enhanced in vitro differentiation of MSCs, which was maximized when the two drugs were combined, with HMA having the dominant effect.
Similar content being viewed by others
References
Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103–107
Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:11–15
Furumatsu T, Ozaki T (2010) Epigenetic regulation in chondrogenesis. Acta Med Okayama 64:155–161
Ghaemi SR, Harding FJ, Delalat B, Gronthos S, Voelcker NH (2013) Exploring the mesenchymal stem cell niche using high throughput screening. Biomaterials 34:7601–7615
Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T (2013) Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots? Stem Cells 31:2033–2041
Hsiao SH, Lee KD, Hsu CC, Tseng MJ, Jin VX, Sun WS et al (2010) DNA methylation of the rip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 400:305–312
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49
Kang PL, Chen CH, Chen SY, Wu YJ, Lin CY, Lin FH et al (2013) Nano-sized collagen I molecules enhanced the differentiation of rat mesenchymal stem cells into cardiomyocytes. J Biomed Mater Res A 101:2808–2816
Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669–1675
Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW et al (2009) Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolifer 42:711–720
Majumder A, Dhara SK, Swetenburg R, Mithani M, Cao K, Medrzycki M et al (2013) Inhibition of DNA methyltransferases and histone deacetylases induces astrocytic differentiation of neural progenitors. Stem Cell Res 11:574–586
Miller JL, Grant PA (2013) The role of DNA methylation and histone modifications in transcriptional regulation in humans. Subcell Biochem 61:289–317
Nakatsuka R, Nozaki T, Uemura Y, Matsuoka Y, Sasaki Y, Shinohara M et al (2010) 5-aza-2′-deoxycytidine treatment induces skeletal myogenic differentiation of mouse dental pulp stem cells. Arch Oral Biol 55:350–357
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Rosca AM, Burlacu A (2011) Effect of 5-azacytidine: evidence for alteration of the multipotent ability of mesenchymal stem cells. Stem Cells Dev 20:1213–1221
Xu S, De Veirman K, Evans H, Santini GC, Vande Broek I, Leleu X et al (2013) Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacol Sin 34:699–709
Acknowledgments
This study was supported by a grant from Sanofi Aventis, Korea. This research was partly supported by the National Research Foundation (NRF) funded by the Korean government (No. NRF-2012R1A1A2043735).
Supporting information
Supplementary Table 1—Primers used for real time-PCR analysis.
Supplementary Fig. 1—Flow cytometric analysis of the MSCs.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kim, H.J., Kwon, YR., Bae, YJ. et al. Enhancement of human mesenchymal stem cell differentiation by combination treatment with 5-azacytidine and trichostatin A. Biotechnol Lett 38, 167–174 (2016). https://doi.org/10.1007/s10529-015-1949-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-015-1949-3